When the threshold of normal transcription of SHP-1 was calculated as the value of the 5th percentile obtained in the healthy control group, we showed that 27 out of 45 MM patients (60%) displayed a significant reduction in SHP-1 gene expression (Fig 1A). The gene discussed is NR0B2; the disease is Miyoshi myopathy.